Longboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the speakers for its...
Source: marketscreener.com